Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Are all ADHD medications created equal? Exploring the differences that enable evening dosing.
Journal: Postgraduate medicine
Published: June 21, 2024
Expert consensus statement for telepsychiatry and attention-deficit hyperactivity disorder.
Journal: CNS spectrums
Published: May 20, 2024
A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials.
Journal: Journal of attention disorders
Published: April 11, 2024
Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: April 02, 2021
Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended-release in children and adolescents with attention-deficit/hyperactivity disorder.
Journal: International journal of clinical practice
Published: February 12, 2021
A randomized, double-blind, 3-way crossover, analog classroom study of SHP465 mixed amphetamine salts extended-release in adolescents with ADHD.
Journal: Postgraduate medicine
Published: January 26, 2019
Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: November 28, 2017
Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers.
Journal: Journal of health economics and outcomes research
Published: October 28, 2016
ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.
Journal: Journal of attention disorders
Published: February 15, 2013
Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges.
Journal: Attention deficit and hyperactivity disorders
Published: January 09, 2013
The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial.
Journal: Journal of attention disorders
Published: June 29, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026